NASDAQ: BNTC
Benitec Biopharma Inc Stock Ownership - Who owns Benitec Biopharma?

Insider buying vs selling

Have Benitec Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Suvretta Capital Management LLCDirector2025-03-31670$13.22
$8.86kBuy
Suvretta Capital Management LLCDirector2025-03-315,057$13.22
$66.85kBuy
Suvretta Capital Management LLCDirector2025-03-311,267$12.63
$16.00kBuy
Suvretta Capital Management LLCDirector2025-03-319,503$12.63
$120.02kBuy
Suvretta Capital Management LLCDirector2025-03-26793,800$13.00
$10.32MBuy
Suvretta Capital Management LLCDirector2025-03-26106,200$13.00
$1.38MBuy
J. Kevin BuchiDirector2025-02-2751,813$3.86
$200.00kBuy
Suvretta Capital Management LLCDirector2024-12-242,288$11.25
$25.74kBuy
Suvretta Capital Management LLCDirector2024-12-2417,730$11.25
$199.46kBuy
Suvretta Capital Management LLCDirector2024-12-2324,360$10.98
$267.47kBuy

1 of 2

BNTC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BNTC insiders and whales buy or sell their stock.

BNTC Shareholders

What type of owners hold Benitec Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Suvretta Capital Management LLC38.58%9,876,506$112.10MInstitution
Janus Henderson Group PLC11.40%2,918,950$33.13MInstitution
Franklin Resources Inc11.17%2,860,726$32.47MInstitution
Adage Capital Partners GP LLC7.71%1,972,524$22.39MInstitution
Suvretta Capital Management LLC5.04%1,289,812$14.64MInsider
Infinitum Asset Management LLC4.39%1,125,000$12.77MInstitution
Nantahala Capital Management LLC3.27%838,095$9.51MInstitution
Steven Michael Oliveira2.61%668,123$7.58MInsider
Vanguard Group Inc1.28%327,034$3.71MInstitution
Schonfeld Strategic Advisors LLC1.02%261,764$2.97MInstitution

1 of 3

BNTC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BNTC85.52%8.18%Net Buying
XOMA18.08%81.92%Net SellingNet Selling
ATXS80.89%19.11%
IVA5.08%0.00%
AARD40.04%46.82%Net Buying

Benitec Biopharma Stock Ownership FAQ

Who owns Benitec Biopharma?

Benitec Biopharma (NASDAQ: BNTC) is owned by 85.52% institutional shareholders, 8.18% Benitec Biopharma insiders, and 6.30% retail investors. Suvretta Capital Management LLC is the largest individual Benitec Biopharma shareholder, owning 1.29M shares representing 5.04% of the company. Suvretta Capital Management LLC's Benitec Biopharma shares are currently valued at $15.09M.

If you're new to stock investing, here's how to buy Benitec Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.